Market Research Logo

Global Artificial Heart Valve Market- Technologies, Market share and Industry Forecast to 2024

Global Artificial Heart Valve Market- Technologies, Market share and Industry Forecast to 2024

Global artificial heart valve market is expected to grow at a CAGR of 12% during the forecast period 2017-2024. Increasing geriatric population and rising cases of heart valve diseases are major growth promotors of the market. Unhealthy lifestyle and lack of physical activities causes various cardiac diseases and pathological disorders. Further, increasing government funding for heart valve research, favorable reimbursement scenario and rising awareness about heart valve diseases are also adding growth in the market. However, high cost and risk associated with transcatheter aortic valve replacement (TAVR) procedures and strict approval process are hindering factor for the market growth.

North America accounted for the largest market share in terms of revenue for the artificial heart valve market in 2017 followed by Europe and Asia Pacific. Factors such as growth in the aging population and rise in the vascular heart diseases and rising product approvals for heart valves are contributing to the growth of North American market. In addition, North America leads market due to greater technological advancement. However, Asia Pacific is expected to be the fastest growing region in the market during the forecast period. Factors such as increasing disposable incomes and growing prevalence of heart valve diseases and improvement in healthcare infrastructure contributes to the growth rate of Asia Pacific artificial heart valve market during the forecast period.

On the basis of segmentation, the artificial heart valve market is segmented on the basis of type of valve. This type of valve segment is further categorized in to three segment those are biological heart valves, mechanical heart valves, and transcatheter heart valves. Transcatheter heart valve devices segment accounts for maximum share in the market. The large share of this segment is due increasing heart valve disease cases and these transcatheter heart valve are planted through minimally invasive procedures and the other type of heart valve type need open heart surgery.

Medtronic Plc (Ireland), Boston Scientific Corporation (U.S.) and Edwards Lifesciences Corporation (U.S.) are amongst the key players of the market. These companies use various strategies such as merger & acquisition, collaboration, partnership and product launch & approvals. Whereas, product approvals is the key strategy adopted by the companies in global artificial heart valve market. For instance, in august 2017, Medtronic Plc announced that its new avalus pericardial surgical valve for the treatment of aortic valve disease has received approval from the U.S. FDA and CE mark (conformite european).

Please note: The delivery time for the electronic version of this report is between 1-3 business days to allow the preparation of an updated version prior to dispatch.


1. INTRODUCTION
1.1. EXECUTIVE SUMMARY
1.2. ESTIMATION METHODOLOGY
2. MARKET OVERVIEW
2.1. GLOBAL ARTIFICIAL HEART VALVE MARKET: EVOLUTION & TRANSITION
2.2. MARKET DEFINITION & SCOPE
2.3. INDUSTRY STRUCTURE
2.4. REGULATORY FRAMEWORK
2.5. TOTAL MARKET ANALYSIS
2.5.1. TOP 5 FINDINGS
2.5.2. TOP 5 OPPORTUNITY MARKETS
2.5.3. TOP 5 COMPANIES
2.5.4. TOP 3 COMPETITIVE STRATEGIES
2.6. ESTIMATION ANALYSIS
2.7. STRATEGIC ANALYSIS
2.7.1. INVESTMENT VS. ADOPTION MODEL
2.7.2. 360-DEGREE INDUSTRY ANALYSIS
2.7.3. PORTERS 5 FORCE MODEL
2.7.4. SEE-SAW ANALYSIS
2.7.5. CONSUMER ANALYSIS AND KEY BUYING CRITERIA
2.8. COMPETITIVE ANALYSIS
2.8.1. KEY STRATEGIES & ANALYSIS
2.8.2. MARKET SHARE ANALYSIS & TOP COMPANY ANALYSIS
2.9. STRATEGIC RECOMMENDATIONS & KEY CONCLUSIONS
2.9.1. INVESTMENT OPPORTUNITIES BY REGIONS
2.9.2. OPPORTUNITIES IN EMERGING APPLICATIONS
2.9.3. INVESTMENT OPPORTUNITY IN FASTEST GROWING SEGMENT
3. MARKET DETERMINANTS
3.1. MARKET DRIVERS
3.1.1. RISING GERIATRIC POPULATION AND LIFE EXPECTANCY RATE
3.1.2. FAVOURABLE COMPENSATION AND REGULATORY APPROVALS
3.1.3. GROWING GOVERNMENT INVESTMENT FOR HEART VALVE RESEARCH AND ANALYSIS
3.1.4. GROWING PREVALENCE OF HEART DISEASES
3.2. MARKET RESTRAINTS
3.2.1. HIGH COST AND RISK ASSOCIATED WITH REPLACEMENT PROCEDURES
3.2.2. STRINGENT REGULATORY APPROVAL PROCESS
3.3. MARKET OPPORTUNITIES
3.3.1. STRONG PRODUCT PIPELINE
3.3.2. HUGE GROWTH OPPORTUNITY IN EMERGING ECONOMIES
3.4. MARKET CHALLENGES
3.4.1. AVALABILITY OF ALTERNATIVE METHODS
4. MARKET SEGMENTATION
4.1. GLOBAL ARTIFICIAL HEART VALVE MARKET BY TYPE OF VALVE
4.1.1. MARKET DEFINITION AND SCOPE
4.1.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.1.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.1.4. OPPORTUNITY MATRIX
4.1.5. MARKET SEGMENTATION
4.1.5.1. GLOBAL TRANSCATHETER HEART VALVES MARKET
4.1.5.1.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.1.2. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
4.1.5.1.3. KEY CONCLUSIONS
4.1.5.2. GLOBAL TISSUE HEART VALVES MARKET
4.1.5.2.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.2.2. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
4.1.5.2.3. KEY CONCLUSIONS
4.1.5.3. GLOBAL MECHANICAL HEART VALVES MARKET
4.1.5.3.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.3.2. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
4.1.5.3.3. KEY CONCLUSIONS
5. COMPETITIVE LANDSCAPE
5.1. KEY STRATEGIES
5.1.1. LIST OF MERGERS AND ACQUISITION
5.1.2. LIST OF JOINT VENTURES
5.1.3. LIST OF PRODUCT LAUNCHES
5.1.4. LIST OF PARTNERSHIPS
6. GEOGRAPHIC ANALYSIS
6.1. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
6.2. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
6.3. OPPORTUNITY MATRIX
6.4. GLOBAL ARTIFICIAL HEART VALVE MARKET BY REGION 2015-2024 ($ MILLION)
6.4.1. NORTH AMERICA
6.4.1.1. INDUSTRY ANALYSIS 2015-2024 ($ MILLION)
6.4.1.2. TOP COUNTRY ANALYSIS
6.4.1.2.1. U.S.
6.4.1.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
6.4.1.2.1.2. KEY CONCLUSIONS
6.4.1.2.2. CANADA
6.4.1.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
6.4.1.2.2.2. KEY CONCLUSIONS
6.4.2. EUROPE
6.4.2.1. INDUSTRY ANALYSIS 2015-2024 ($ MILLION)
6.4.2.2. TOP COUNTRY ANALYSIS
6.4.2.2.1. UK
6.4.2.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
6.4.2.2.1.2. KEY CONCLUSIONS
6.4.2.2.2. FRANCE
6.4.2.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
6.4.2.2.2.2. KEY PLAYERS & KEY PRODUCTS
6.4.2.2.2.3. KEY CONCLUSIONS
6.4.2.2.3. GERMANY
6.4.2.2.3.1. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
6.4.2.2.3.2. KEY CONCLUSIONS
6.4.2.2.4. SPAIN
6.4.2.2.4.1. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
6.4.2.2.4.2. KEY CONCLUSIONS
6.4.2.2.5. REST OF EUROPE
6.4.2.2.5.1. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
6.4.2.2.5.2. KEY CONCLUSIONS
6.4.3. ASIA PACIFIC
6.4.3.1. INDUSTRY ANALYSIS 2015-2024 ($ MILLION)
6.4.3.2. TOP COUNTRY ANALYSIS
6.4.3.2.1. CHINA
6.4.3.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
6.4.3.2.1.2. KEY CONCLUSIONS
6.4.3.2.2. INDIA
6.4.3.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
6.4.3.2.2.2. KEY CONCLUSIONS
6.4.3.2.3. JAPAN
6.4.3.2.3.1. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
6.4.3.2.3.2. KEY CONCLUSIONS
6.4.3.2.4. AUSTRALIA
6.4.3.2.4.1. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
6.4.3.2.4.2. KEY CONCLUSIONS
6.4.3.2.5. REST OF ASIA PACIFIC
6.4.3.2.5.1. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
6.4.3.2.5.2. KEY CONCLUSIONS
6.4.4. ROW
6.4.4.1. INDUSTRY ANALYSIS 2015-2024 ($ MILLION)
6.4.4.2. TOP COUNTRY ANALYSIS
6.4.4.2.1. LATIN AMERICA
6.4.4.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
6.4.4.2.1.2. KEY CONCLUSIONS
6.4.4.2.2. MIDDLE EAST & AFRICA
6.4.4.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
6.4.4.2.2.2. KEY CONCLUSIONS
7. COMPANY PROFILES
7.1. BOSTON SCIENTIFIC CORPORATION (U.S.)
7.1.1. OVERVIEW
7.1.2. PRODUCT PORTFOLIO
7.1.3. STRATEGIC INITIATIVES
7.1.4. SCOT ANALYSIS
7.1.5. STRATEGIC ANALYSIS
7.2. BRAILE BIOMEDICA (BRAZIL)
7.2.1. OVERVIEW
7.2.2. PRODUCT PORTFOLIO
7.2.3. STRATEGIC INITIATIVES
7.2.4. SCOT ANALYSIS
7.2.5. STRATEGIC ANALYSIS
7.3. COLIBRI HEART VALVE, LLC (U.S.)
7.3.1. OVERVIEW
7.3.2. PRODUCT PORTFOLIO
7.3.3. STRATEGIC INITIATIVES
7.3.4. SCOT ANALYSIS
7.3.5. STRATEGIC ANALYSIS
7.4. CRYOLIFE, INC. (U.S.)
7.4.1. OVERVIEW
7.4.2. PRODUCT PORTFOLIO
7.4.3. STRATEGIC INITIATIVES
7.4.4. SCOT ANALYSIS
7.4.5. STRATEGIC ANALYSIS
7.5. EDWARDS LIFESCIENCES CORPORATION (U.S.)
7.5.1. OVERVIEW
7.5.2. PRODUCT PORTFOLIO
7.5.3. STRATEGIC INITIATIVES
7.5.4. SCOT ANALYSIS
7.5.5. STRATEGIC ANALYSIS
7.6. HEART LEAFLET TECHNOLOGY (U.S.)
7.6.1. OVERVIEW
7.6.2. PRODUCT PORTFOLIO
7.6.3. STRATEGIC INITIATIVES
7.6.4. SCOT ANALYSIS
7.6.5. STRATEGIC ANALYSIS
7.7. JENAVALVE TECHNOLOGY, INC.(GERMANY)
7.7.1. OVERVIEW
7.7.2. PRODUCT PORTFOLIO
7.7.3. STRATEGIC INITIATIVES
7.7.4. SCOT ANALYSIS
7.7.5. STRATEGIC ANALYSIS
7.8. LIVANOVA PLC (U.K.),
7.8.1. OVERVIEW
7.8.2. PRODUCT PORTFOLIO
7.8.3. STRATEGIC INITIATIVES
7.8.4. SCOT ANALYSIS
7.8.5. STRATEGIC ANALYSIS
7.9. LEPU MEDICAL TECHNOLOGY CO LTD (CHINA)
7.9.1. OVERVIEW
7.9.2. PRODUCT PORTFOLIO
7.9.3. STRATEGIC INITIATIVES
7.9.4. SCOT ANALYSIS
7.9.5. STRATEGIC ANALYSIS
7.10. LEMAN CARDIOVASCULAR (SWITZERLAND)
7.10.1. OVERVIEW
7.10.2. PRODUCT PORTFOLIO
7.10.3. STRATEGIC INITIATIVES
7.10.4. SCOT ANALYSIS
7.10.5. STRATEGIC ANALYSIS
7.11. MEDTRONIC PLC (IRELAND)
7.11.1. OVERVIEW
7.11.2. PRODUCT PORTFOLIO
7.11.3. STRATEGIC INITIATIVES
7.11.4. SCOT ANALYSIS
7.11.5. STRATEGIC ANALYSIS
7.12. MICRO INTERVENTIONAL DEVICES, INC. (U.S.)
7.12.1. OVERVIEW
7.12.2. PRODUCT PORTFOLIO
7.12.3. STRATEGIC INITIATIVES
7.12.4. SCOT ANALYSIS
7.12.5. STRATEGIC ANALYSIS
7.13. ST. JUDE MEDICAL, INC. (AN ABBOTT LABORATORIES COMPANY) (U.S.)
7.13.1. OVERVIEW
7.13.2. PRODUCT PORTFOLIO
7.13.3. STRATEGIC INITIATIVES
7.13.4. SCOT ANALYSIS
7.13.5. STRATEGIC ANALYSIS
7.14. SYMETIS SA (SWITZERLAND)
7.14.1. OVERVIEW
7.14.2. PRODUCT PORTFOLIO
7.14.3. STRATEGIC INITIATIVES
7.14.4. SCOT ANALYSIS
7.14.5. STRATEGIC ANALYSIS
7.15. TTK HEALTHCARE LIMITED (A TTK GROUP COMPANY) (INDIA)
7.15.1. OVERVIEW
7.15.2. PRODUCT PORTFOLIO
7.15.3. STRATEGIC INITIATIVES
7.15.4. SCOT ANALYSIS
7.15.5. STRATEGIC ANALYSIS
LIST OF TABLES
GLOBAL ARTIFICIAL HEART VALVE MARKET BY TYPE OF VALVE 2015-2024 ($ MILLION)
GLOBAL TRANSCATHETER HEART VALVES MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)
GLOBAL TISSUE HEART VALVES MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)
GLOBAL MECHANICAL HEART VALVES MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)
NORTH AMERICA ARTIFICIAL HEART VALVE MARKET 2015-2024 ($ MILLION)
EUROPE ARTIFICIAL HEART VALVE MARKET 2015-2024 ($ MILLION)
ASIA PACIFIC ARTIFICIAL HEART VALVE MARKET 2015-2024 ($ MILLION)
REST OF THE WORLD ARTIFICIAL HEART VALVE MARKET 2015-2024 ($ MILLION)
NORTH AMERICA ARTIFICIAL HEART VALVE MARKET BY TYPE OF VALVE 2015-2024 ($ MILLION)
EUROPE ARTIFICIAL HEART VALVE MARKET BY TYPE OF VALVE 2015-2024 ($ MILLION)
ASIA PACIFIC ARTIFICIAL HEART VALVE MARKET BY TYPE OF VALVE 2015-2024 ($ MILLION)
REST OF THE WORLD ARTIFICIAL HEART VALVE MARKET BY TYPE OF VALVE 2015-2024 ($ MILLION)
UNITED STATES (U.S.) ARTIFICIAL HEART VALVE MARKET BY TYPE OF VALVE 2015-2024 ($ MILLION)
CANADA ARTIFICIAL HEART VALVE MARKET BY TYPE OF VALVE 2015-2024 ($ MILLION)
UNITED KINGDOM (UK) ARTIFICIAL HEART VALVE MARKET BY TYPE OF VALVE 2015-2024 ($ MILLION)
FRANCE ARTIFICIAL HEART VALVE MARKET BY TYPE OF VALVE 2015-2024 ($ MILLION)
GERMANY ARTIFICIAL HEART VALVE MARKET BY TYPE OF VALVE 2015-2024 ($ MILLION)
SPAIN ARTIFICIAL HEART VALVE MARKET BY TYPE OF VALVE 2015-2024 ($ MILLION)
ROE ARTIFICIAL HEART VALVE MARKET BY TYPE OF VALVE 2015-2024 ($ MILLION)
INDIA ARTIFICIAL HEART VALVE MARKET BY TYPE OF VALVE 2015-2024 ($ MILLION)
CHINA ARTIFICIAL HEART VALVE MARKET BY TYPE OF VALVE 2015-2024 ($ MILLION)
JAPAN ARTIFICIAL HEART VALVE MARKET BY TYPE OF VALVE 2015-2024 ($ MILLION)
AUSTRALIA ARTIFICIAL HEART VALVE MARKET BY TYPE OF VALVE 2015-2024 ($ MILLION)
ROAPAC ARTIFICIAL HEART VALVE MARKET BY TYPE OF VALVE 2015-2024 ($ MILLION)
LATIN AMERICA ARTIFICIAL HEART VALVE MARKET BY TYPE OF VALVE 2015-2024 ($ MILLION)
MENA ARTIFICIAL HEART VALVE MARKET BY TYPE OF VALVE 2015-2024 ($ MILLION)
LIST OF FIGURES
GLOBAL TRANSCATHETER HEART VALVES MARKET 2015-2024 ($ MILLION)
GLOBAL TISSUE HEART VALVES MARKET 2015-2024 ($ MILLION)
GLOBAL MECHANICAL HEART VALVES MARKET 2015-2024 ($ MILLION)
UNITED STATES (U.S.) ARTIFICIAL HEART VALVE MARKET 2015-2024 ($ MILLION)
CANADA ARTIFICIAL HEART VALVE MARKET 2015-2024 ($ MILLION)
UNITED KINGDOM (UK) ARTIFICIAL HEART VALVE MARKET 2015-2024 ($ MILLION)
FRANCE ARTIFICIAL HEART VALVE MARKET 2015-2024 ($ MILLION)
GERMANY ARTIFICIAL HEART VALVE MARKET 2015-2024 ($ MILLION)
SPAIN ARTIFICIAL HEART VALVE MARKET 2015-2024 ($ MILLION)
ROE ARTIFICIAL HEART VALVE MARKET 2015-2024 ($ MILLION)
INDIA ARTIFICIAL HEART VALVE MARKET 2015-2024 ($ MILLION)
CHINA ARTIFICIAL HEART VALVE MARKET 2015-2024 ($ MILLION)
JAPAN ARTIFICIAL HEART VALVE MARKET 2015-2024 ($ MILLION)
AUSTRALIA ARTIFICIAL HEART VALVE MARKET 2015-2024 ($ MILLION)
ROAPAC ARTIFICIAL HEART VALVE MARKET 2015-2024 ($ MILLION)
LATIN AMERICA ARTIFICIAL HEART VALVE MARKET 2015-2024 ($ MILLION)
MENA ARTIFICIAL HEART VALVE MARKET 2015-2024 ($ MILLION)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report